No, Your Drug Or Medical Device Case Is Not Part Of A Class Action


Clients deciding whether to file a pharmaceutical or medical device case often ask a common question:  Will my case become part of a class action?  This question—or concern—arises from the perception that class action lawsuits usually result in a very limited recovery for each member of the class.  Understandably, if you have been injured by a defective drug or medical device, and facing the prospect of a potentially long and emotional legal action, the last thing you want to think about is a limited recovery.  Fortunately, there are significant differences between class actions and drug and device litigation, and drug and device litigations will usually provide sufficient recovery to the injured party.

Lawsuits related to defective drugs or medical devices will often involve claims brought by hundreds or thousands of individuals who used the drug or device and were ultimately injured in a similar way.  A common practice in federal court is to consolidate all of the cases in a single court where they can be coordinated and handled by a single judge.  This coordination is commonly referred to as a “mass tort.”  In a mass tort action, plaintiffs’ attorneys will usually work collectively to build a case against the defendant with the expectation that the judge will eventually order all of the cases to be sent back to the court of original jurisdiction

In drug and device cases that are coordinated as a mass tort, the individual plaintiff retains several important rights not available in a class action.  To start, the plaintiff continues to maintain an individual lawsuit and has the right to make decisions related to the individual lawsuit.  For example, the plaintiff can never be forced to have a trial in any court other than the court of original jurisdiction.  Although a plaintiff can waive that right in favor of having the mass tort judge preside over the trial, it is a decision that only the individual can make.  In addition, as compared to a class action that is adverse to considerations of individual issues, the individual facts surrounding the use of the pharmaceutical or medical device will remain an important factor in the progress of the lawsuit. Finally, and maybe most importantly, at the appropriate time the individual alone retains the right to decide whether to settle the individual lawsuit or to continue to move forward toward trial.

In contrast, a class action is filed by a single or small number of “named representatives” who seek to represent the interests of an entire class of individuals in a single lawsuit.  Class actions are typically considered the best method of litigating cases where a large number of individuals have been damaged for a relatively small amount of money.  Generally speaking, the key difference is that class actions do not involve personal injuries.  As soon as practicable after the filing of the class action the named representatives will ask the court to certify the action as a class action.  If the class action is certified and appropriate notice is provided to class members the class members may be bound by the results of the single class action lawsuit.


The postings on this blog were created for general informational purposes only and do not constitute legal advice or a solicitation to provide legal services.  Although we attempt to ensure that the postings are complete, accurate, and current as of the time of publication, we assume no responsibility for their completeness, accuracy, or timeliness.  The information in this blog is not intended to create, and receipt of it does not constitute, a lawyer-client relationship.  Readers should not act upon this information without seeking professional legal counsel.

This blog may contain links to independent third party websites and services, including social media. We provide these links for your convenience, and you access them at your own risk.  We have no control over and do not monitor the content or policies (including privacy policies) of these third-party websites and have no responsibility for, and no liability with respect to, their content, accuracy, or reliability.  Unless expressly stated, we do not endorse any of the linked websites or any product, service, or publication referenced herein or therein.  We will remove a link to any site from this blog upon request of the linked entity.

We grant permission to readers to link to this blog so long as this blog is not misrepresented. This site is not sponsored or associated with any other site unless so identified.

If you wish for Wilentz, Goldman & Spitzer, P.A., to consider representing you, please obtain contact information from the Contact Us area of this blog or go to the firm’s website at  One of our lawyers will be happy to discuss the possibility of representation with you. However, the authors of Wilentz blogs are licensed only in New Jersey and/or New York and do not wish to represent anyone who viewed this site in a state where the site fails to comply with all laws and ethical rules of that state.

Thank you for your interest in Wilentz, Goldman & Spitzer P.A.’s legal blogs. You will receive an email sent to the address entered in order to confirm your subscription. Please watch for it and click the link to confirm your subscription.